Ginkgo Bioworks Raises $3 billion SPAC

Company profile · Healthcare & Life Sciences · Updated Recent

Ginkgo Bioworks has raised $3B in SPAC funding led by Various, with participation from Various (SPAC). AI cell programming platform for synthetic biology.

SPAC$3 billionTotal tracked $3 billionBoston, MA

What it does

AI cell programming platform for synthetic biology

Traction

Ginkgo Bioworks is continuing to scale after securing $3B in SPAC funding led by Various, with participation from Various (SPAC).

Trend impact

MD-grade thesis held: available source material is not specific enough to support a non-generic investor-economist read without overclaiming.

Funding history

Recent · SPAC · $3 billion · Various

Products & services

Healthcare & Life Sciences workflow monitoring tied to the funding announcement
Customer-facing product described on the company website
Operational tooling for healthcare & life sciences teams
Data capture and reporting across core business processes
Team expansion support funded by the latest round

Open Ginkgo Bioworks in the interactive Capvizr dashboard →